Clinical value of c-reactive protein level in predicting the development of postpartum endometritis

Cover Page


Cite item

Abstract

Hypothesis/aims of study. In the Russian Federation, postpartum septic complications are third among the causes of maternal mortality, along with obstetric bleeding and preeclampsia. A wide range of methods for predicting postpartum endometritis has been proposed. However, none of these methods has sufficient clinical efficacy. The lack of information and the lack of clear criteria highlight the difficulties in the early diagnosis and prognosis of postpartum endometritis. The aim of this study was to evaluate the role of C-reactive protein (CRP) in the prediction of postpartum endometritis in puerperas with a high risk of developing septic complications.

Study design, materials and methods. The study included 135 puerperas, who were retrospectively divided into two groups. The main group consisted of women with developed postpartum endometritis (n = 72), and the comparison group comprised individuals with physiological course of the postpartum period (n = 63). Serum CRP levels were determined for all puerperas on days 1 and 3 of the postpartum period using the immunoturbodimetric method.

Results. On day 1 of the postpartum period, the diagnostic threshold value for CRP levels was 69 mg / ml. The sensitivity and specificity of the method were low: 62% (95% CI 50–74) and 65% (95% CI 51–76), respectively. The predictability at a CRP level above 69 mg / ml was 67% (95% CI 54–77). Thus, in puerperas on day 1 of the postpartum period at a CRP level above 69 mg / ml, the probability of developing postpartum endometritis was 67%, the chances of developing postpartum endometritis being extremely low, increasing by 1.76 times. There were no statistically significant differences when comparing CRP levels in the study groups of puerperas on day 1 of the postpartum period. On day 3 of the postpartum period, CRP level was significantly higher in the main group of puerperas — 148 mg / ml (95% CI 126–171), and in the comparison group — 43 mg / ml (95% CI 38–49) (p = 6 × 10–14). On the 3rd day of the postpartum period, the diagnostic threshold value for CRP levels was 60 mg / ml. The sensitivity of the method was moderate — 79% (95% CI 68–86), the specificity of the method being high — 93% (95% CI 85–98). The predictability at a CRP level above 60 mg / ml was 93% (95% CI 84–96). Thus, in postpartum women on day 3 of the postpartum period at a CRP level above 60 mg / ml, the probability of developing postpartum endometritis was 93%, with the chances of developing postpartum endometritis increased by 10 times (95% CI 5–30). In addition, determining CRP level on day 3 of the postpartum period is clinically informative, as evidenced by the standardized effect size (SES) equal to 1.4 (p = 6 × 10–14). This is confirmed by the ROC analysis data: the clinical significance value (AUC indicator) was 0.89 (CI 0.81–0.93), according to which CRP determination is evaluated as a method with high clinical informativity.

Conclusion. The determination of CRP on day 3 of the postpartum period is a clinically informative method. An increase in CRP level above 60 mg / ml is a predictor of postpartum endometritis with a sensitivity of 79% and a high probability (93%).

About the authors

Tatyana V. Batrakova

V.A. Almazov National Medical Research Center

Author for correspondence.
Email: tatyana_shuranov@mail.ru
ORCID iD: 0000-0002-5710-9416
SPIN-code: 3042-2856

MD, Post-Graduate Student. The Department of Obstetrics and Gynecology, the Faculty of Medicine, the Institute of Medical Education

Russian Federation, Saint Petersburg

Irina E. Zazerskaya

V.A. Almazov National Medical Research Center

Email: zazera@almazovcentre.com
ORCID iD: 0000-0003-4431-3917
SPIN-code: 5683-6741

MD, PhD, DSci (Medicine), the Head of the Department of Obstetrics and Gynecology. The Faculty of Medicine, the Institute of Medical Education

Russian Federation, Saint Petersburg

Tatyana V. Vavilova

V.A. Almazov National Medical Research Center

Email: Vavilova_TV@almazovcentre.ru
SPIN-code: 9003-6455

MD, PhD, DSci (Medicine), Professor, the Head of the Department of Laboratory Medicine and Genetics. The Faculty of Medicine, the Institute of Medical Education

Russian Federation, Saint Petersburg

Vitaly N. Kustarov

V.A. Almazov National Medical Research Center

Email: zazera@almazovcentre.com

MD, PhD, DSci (Medicine), Professor. The Department of Obstetrics and Gynecology, the Faculty of Medicine, the Institute of Medical Education

Russian Federation, Saint Petersburg

References

  1. Анохова Л.И., Белокриницкая Т.Е., Патеюк А.В., Кохан С.Т. Послеродовой эндометрит и его профилактика (обзор литературы) // Научное обозрение. Медицинские науки. – 2016. – № 4. – С. 6−13. [Anokhova LI, Belokrinitskaya TE, Pateyuk AV, Kokhan ST. Postnatal endometritis and its prevention (review of literature). Science review. Medical science. 2016;(4):6-13. (In Russ.)]
  2. Батракова Т.В., Вавилова Т.В., Осипова Н.А. Роль острофазных белков в диагностике послеродового эндометрита (обзор литературы) // Гинекология. – 2016. – Т. 18. – № 1. – С. 37–39. [Batrakova TV, Vavilova TV, Osipova NA. Role of acute-phase proteins in postpartum endometritis diagnostics (review of literature). Gynaecology. 2016;18(1):37-39. (In Russ.)]. https://doi.org/10.26442/2079-5696_18.1.37-39.
  3. Вельков В.В. Комплексная лабораторная диагностика системных инфекций и сепсиса: С-реактивный белок, прокальцитонин, пресепсин. – М.: Диакон, 2015. – 117 с. [Vel’kov VV. Kompleksnaya laboratornaya diagnostika sistemnykh infektsiy i sepsisa: C-reaktivnyy belok, prokal’tsitonin, presepsin. Moscow: Diacon; 2015. 117 р. (In Russ.)]
  4. Начальная терапия сепсиса и септического шока в акушерстве. Клинические рекомендации (протоколы лечения) [интернет]. 2014. [Nachal’naya terapiya sepsisa i septicheskogo shoka v akusherstve. Klinicheskie rekomendatsii (protokoly lecheniya) [Internet]. 2014. (In Russ.)]. Доступ по: https://www.critical.ru/consult/pages/init-threpy-sepsis.pdf. Ссылка активна на 14.12.2019.
  5. Бондаренко К.Р., Доброхотова Ю.Э., Новик М.Ю. Возможности профилактики поздних акушерских осложнений путем коррекции эндогенной микробиоты // Медицинский алфавит. – 2017. – Т. 3. – № 23. – С. 6−14. [Bondarenko KR, Dobrokhotova YE, Novik MU. Approaches in prevention of late pregnancy complications by correction of endogenous microbiota. Medical alphabet. 2017;3(23):6-14. (In Russ.)]
  6. Газазян М.Г., Аджиева Д.Н. Снижение воспалительных осложнений при оперативном родоразрешении // Современные проблемы науки и образования. – 2015. – № 4. – С. 8−10. [Gazazyan MG, Adzhieva DN. Decrease in inflammatory complications of operational delivery. Modern problems of science and education. 2015;(4):8-10. (In Russ.)]
  7. Письмо Министерства здравоохранения РФ от 6 февраля 2017 г. № 15-4/10/2-728. Септические состояния в акушерстве. Клинические рекомендации (протокол лечения) [интернет]. [Letter from the Ministry of health of the Russian Federation № 15-4/10/2-728, dated 2017 February 6. Septicheskie sostoyaniya v akusherstve. Klinicheskie rekomendatsii (protokol lecheniya) [Internet]. (In Russ.)]. Доступ по: https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/ag/031.pdf. Ссылка активна на 14.12.2019.
  8. Самойлова Т.Н., Кохно Н.И., Докудаева Д.Ш. Микробные ассоциации при послеродовом эндометрите // Русский медицинский журнал. Медицинское обозрение. – 2018. – Т. 2. – № 10. – С. 6−13. [Samoilova TE, Kokhno NI, Dokudaeva ShA. Mikrobnyye assotsiatsii pri poslerodovom endometrite. Russkiy meditsinskiy zhurnal. Meditsinskoye obozreniye. 2018;2(10):6-13. (In Russ.)]
  9. Федеральная служба государственной статистики. Состояние здоровья беременных, рожениц, родильниц и новорожденных [интернет]. [Federal’naya sluzhba gosudarstvennoy statistiki. Sostoyanie zdorov’ya beremennykh, rozhenits, rodil’nits i novorozhdennykh [Internet]. (In Russ.)]. Доступ по: https://www.gks.ru/storage/mediabank/zdr3-2.xls. Ссылка активна на 14.12.2019.
  10. Albright CM, Mehta ND, Rouse DJ, Hughes BL. Sepsis in pregnancy: identification and management. J Perinat Neonatal Nurs. 2016;30(2):95-105. https://doi.org/10.1097/jpn.0000000000000159.
  11. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-810. https://doi.org/10.1001/jama.2016.0287.
  12. Nishida O, Ogura H, Egi M, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016). Acute Med Surg. 2018;5(1):3-8. https://doi.org/10.2199/jjsca.37.805.
  13. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75-87. https://doi.org/ 10.1016/s0140-6736(18)30696-2.
  14. Armstrong BA, Betzold RD, May AK. Sepsis and septic shock strategies. Surg Clin North Am. 2017;97(6):1339-1379. https://doi.org/10.1016/j.suc.2017.07.003.
  15. Bowyer L, Robinson HL, Barrett H, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy. Aust N Z J Obstet Gynaecol. 2017;57(5):540-551. https://doi.org/10.1111/ajo.12646.
  16. Biller K, Fae F, Germann R, et al. Wie verlässlich ist die bestimmung von procalcitonin als entzündungsmarker auf intensivstation? / How reliable is procalcitonin as an inflammatory marker? J Lab Med. 2011;35(6):343-348. https://doi.org/10.1515/jlm.2011.058.
  17. World Health Organization [Internet]. Sexual and reproductive health. Statement on maternal sepsis. WHO reference number: WHO/RHR/17.02. Geneva: WHO; 2017. Available from: https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/maternalsepsis-statement/en/.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Graphical analysis of CRP levels in the study groups on day 3 of the postpartum period. The 95% CI is indicated as subscripts

Download (19KB)
3. Fig. 2. ROC analysis of the evaluation of clinical informativity of C-reactive protein level. The 95% CI is indicated as subscripts

Download (131KB)

Copyright (c) 2020 Batrakova T.V., Zazerskaya I.E., Vavilova T.V., Kustarov V.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies